Novavax Inc (NVAX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2013 | 06-2013 | 03-2013 | 12-2012 | 09-2012 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 122,617 | 2,574 | 9,240 | 18,385 | 11,576 |
| Marketable Securities | 23,917 | 38,025 | 35,256 | 26,712 | 17,672 |
| Receivables | 5,105 | 2,722 | 4,173 | 2,581 | 4,194 |
| Other current assets | 365 | 20 | 886 | 171 | 235 |
| TOTAL | $155,020 | $45,365 | $51,722 | $50,408 | $36,484 |
| Non-Current Assets | |||||
| PPE Net | 13,969 | 13,320 | 11,617 | 11,456 | 9,815 |
| Investments And Advances | 0 | 0 | 1,117 | 6,233 | 0 |
| Intangibles | 75,164 | 33,141 | 33,141 | 33,141 | 33,141 |
| Other Non-Current Assets | 921 | 1,092 | 1,107 | 1,107 | 1,106 |
| TOTAL | $90,054 | $47,553 | $46,982 | $51,937 | $44,062 |
| Total Assets | $245,074 | $92,918 | $98,704 | $102,345 | $80,546 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | N/A | 58 | N/A |
| Accounts payable and accrued liabilities | 3,339 | 2,946 | 2,173 | 3,228 | 2,203 |
| Accrued Expenses | 9,553 | 7,223 | 5,842 | 7,275 | 6,031 |
| Other current liabilities | 0 | N/A | 267 | 267 | 769 |
| TOTAL | $14,260 | $11,256 | $9,253 | $11,675 | $10,441 |
| Non-Current Liabilities | |||||
| Long Term Debt | 1,653 | 1,653 | 1,290 | 990 | 793 |
| Deferred Revenues | 656 | 456 | 522 | 690 | 1,224 |
| Other Non-Current Liabilities | 1,578 | 0 | 0 | 0 | 0 |
| TOTAL | $14,240 | $12,436 | $11,883 | $10,430 | $8,729 |
| Total Liabilities | $28,500 | $23,692 | $21,136 | $22,105 | $19,170 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 10,426 | 7,636 | 7,623 | 7,397 | 7,397 |
| Common Shares | 2,090 | 1,532 | 1,517 | 1,484 | 1,360 |
| Retained earnings | -396,092 | -380,793 | -368,159 | -358,163 | -350,128 |
| Other shareholders' equity | 663 | 187 | 19 | -20 | 586 |
| TOTAL | $216,574 | $69,226 | $77,568 | $80,240 | $61,376 |
| Total Liabilities And Equity | $245,074 | $92,918 | $98,704 | $102,345 | $80,546 |